Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-24 | 361.22 | 4.07 | (13.18)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-25 | 445.15 | 105.13 | 8.91p | 4.8 | n/a | n/a | n/a | 0.0% |
30-Jun-26 | 468.27 | 76.25 | 9.06p | 4.7 | 2.8 | +2% | 1.97p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Current | 1 week ago | 1 month ago | 3 months ago | 6 months ago | 1 year ago | |
---|---|---|---|---|---|---|
Revenue (£m) | ||||||
30-Jun-2024 | 361 | 361 | n/a | n/a | n/a | n/a |
30-Jun-2025 | 445 | 445 | n/a | n/a | n/a | n/a |
30-Jun-2026 | 468 | 468 | n/a | n/a | n/a | n/a |
Earnings | ||||||
30-Jun-2024 | n/a | n/a | n/a | n/a | n/a | n/a |
30-Jun-2025 | 8.91p | 8.89p | n/a | n/a | n/a | n/a |
30-Jun-2026 | 9.06p | 9.04p | n/a | n/a | n/a | n/a |
Dividend | ||||||
30-Jun-2024 | n/a | n/a | n/a | n/a | n/a | n/a |
30-Jun-2025 | n/a | n/a | n/a | n/a | n/a | n/a |
30-Jun-2026 | 1.97p | 1.96p | n/a | n/a | n/a | n/a |
Recommendations | ||||||
Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Neutral | 3 | 3 | 0 | 0 | 0 | 0 |
Sell | 1 | 1 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Brokers | 5 | 5 | 0 | 0 | 0 | 0 |
Average Rec | 5.50 | 5.50 | n/a | n/a | n/a | n/a |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 42.90p |
Change Today | 0.80p |
% Change | 1.90 % |
52 Week High | 76.50 |
52 Week Low | 37.00 |
Volume | 39,876 |
Shares Issued | 194.20m |
Market Cap | £83.31m |
RiskGrade | 380 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 3 |
Sell | 1 |
Strong Sell | 0 |
Total | 5 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | n/a | 15-Oct-15 |
Paid | n/a | 07-Dec-15 |
Amount | 0.000¢ | 3.00¢ |
Time | Volume / Share Price |
16:35 | 959 @ 42.90p |
16:35 | 38 @ 42.90p |
16:35 | 153 @ 42.90p |
16:35 | 13 @ 42.90p |
16:35 | 20 @ 42.90p |
Finance Director | Jacques Breytenbach |
Chair | Varda Shine |
CEO | Richard Duffy |
You are here: research